Another full-regimen HIV pill enters the market: Triumeq

August 22, 2014 - Project Inform.

Convenient options for treating HIV infection got a boost today as the new all-in-one pill called Triumeq was approved by the FDA. Triumeq is a full HIV regimen made up of the three drugs dolutegravir (Tivicay), abacavir (Ziagen) and lamivudine (Epivir). Dolutegravir is an integrase inhibitor while the other two drugs are NRTIs, also available as Epzicom. Four full-regimen pills are now available as HIV treatment: Triumeq, Stribild, Complera and Atripla.

This is the first all-in-one HIV pill approved by the FDA without Truvada (tenofovir/emtricitabine), which makes it a new choice for those with impaired kidney function. Continue reading…

 

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name
Sat, 6/27/2015 - 1:16pm
Sat, 6/27/2015 - 1:10pm
Fri, 6/26/2015 - 12:02am

Learn what parents and providers need to know about HIV risk factors specific to teens and the importance of talking to your teen about HIV.

Learn about substance abuse, dependence, and addiction, how they affect living with HIV, how to know if you have a problem, and what to do.

Get basic information about a variety of approaches to treating the metabolic changes that may result from HIV disease or HIV drugs. 

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>